Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX)

40 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63,858,418 shares of 176,391,745 outstanding shares and own 36% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (21,960,850 shares), FMR LLC (6,354,814 shares), Rock Springs Capital Management LP (5,333,188 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4,606,600 shares), Foresite Capital Management V, LLC (4,400,000 shares), JANUS HENDERSON GROUP PLC (3,522,980 shares), CHI Advisors LLC (2,829,712 shares), VANGUARD GROUP INC (2,380,623 shares), Vivo Capital, LLC (2,000,000 shares), and Avidity Partners Management LP (2,000,000 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.